US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 1.8100
  • +0.0400+2.26%
Close Dec 13 16:00 ET
  • 1.7607
  • -0.0493-2.72%
Post 20:02 ET
3.48MMarket Cap-1.89P/E (TTM)

Sonnet BioTherapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.27%-3.07M
115.41%723.79K
47.73%-3.09M
23.16%-21.34M
27.03%-4.56M
21.12%-6.17M
16.28%-4.7M
26.90%-5.92M
-23.15%-27.77M
-5.22%-6.25M
Net income from continuing operations
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
Depreciation and amortization
10.87%21.04K
8.60%20.5K
8.35%19.97K
-18.77%75.75K
8.58%19.47K
-19.91%18.98K
-27.93%18.87K
-27.56%18.43K
-2.00%93.26K
-27.67%17.93K
Other non cash items
--360.16K
--0
-88.00%12K
-70.97%282K
----
----
-92.75%12K
-16.67%100K
155,835.31%971.48K
----
Change In working capital
99.28%-17.65K
-68.60%277.48K
-243.90%-2.01M
-43,305.16%-3.12M
-196.70%-951.85K
-270.29%-2.46M
-57.05%883.67K
75.39%-583.08K
-99.34%7.21K
46.59%984.37K
-Change in receivables
53.12%-141.65K
-120.67%-183.85K
195.69%592.46K
90.34%-69.27K
94.79%-37.41K
---302.16K
--889.41K
---619.12K
---717.31K
---717.31K
-Change in prepaid assets
100.77%5.01K
-0.85%349.44K
225.52%269.12K
92.59%-33.65K
-38.36%185.29K
1.53%-654.04K
432.15%352.43K
435.20%82.67K
49.62%-454.27K
217.76%300.6K
-Change in payables and accrued expense
110.88%141.39K
138.25%122.61K
-35,299.17%-2.75M
-248.80%-2.4M
-153.15%-786.91K
-1,680.12%-1.3M
-114.05%-320.55K
100.35%7.82K
-18.17%1.61M
3.39%1.48M
-Change in other current assets
97.66%-3.64K
--7.02K
---77.66K
---414.21K
---258.84K
---155.37K
--0
--0
--0
--0
-Change in other current liabilities
-15.56%-18.75K
-1,403.98%-17.75K
-0.14%-17.23K
38.66%-51.33K
-0.16%-16.72K
24.39%-16.23K
94.93%-1.18K
22.63%-17.2K
-1.98%-83.69K
22.61%-16.69K
-Change in other working capital
--0
--0
50.00%-18.63K
57.76%-147.81K
40.63%-37.26K
40.63%-36.85K
61.77%-36.45K
71.30%-37.26K
-2,237.19%-349.94K
87.02%-62.75K
Cash from discontinued investing activities
Operating cash flow
50.27%-3.07M
115.41%723.79K
47.73%-3.09M
23.16%-21.34M
27.03%-4.56M
21.12%-6.17M
16.28%-4.7M
26.90%-5.92M
-23.15%-27.77M
-5.22%-6.25M
Investing cash flow
Cash flow from continuing investing activities
0.00%-12K
45.29%-443.25K
-375.75%-170K
97.95%-12K
-22,263.43%-810.23K
1,801.63%61.65K
Net intangibles purchase and sale
0.00%-12K
----
----
45.29%-443.25K
-375.75%-170K
97.95%-12K
----
----
---810.23K
--61.65K
Cash from discontinued investing activities
Investing cash flow
0.00%-12K
----
----
45.29%-443.25K
-375.75%-170K
97.95%-12K
----
----
-22,263.43%-810.23K
1,801.63%61.65K
Financing cash flow
Cash flow from continuing financing activities
57.02%2.85M
-99.72%41K
-15.87%3.84M
423.26%21.01M
-100.44%-17.7K
1.81M
14.65M
4.56M
-90.63%4.01M
-85.42%4.01M
Net issuance payments of debt
----
----
----
---748
--0
----
----
----
--0
--0
Net common stock issuance
-96.68%60.29K
--0
-15.87%3.84M
1,040.46%21.01M
-100.96%-17.7K
--1.81M
--14.65M
--4.56M
-95.70%1.84M
-93.31%1.84M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--2.17M
----
Proceeds from stock option exercised by employees
347,010.48%2.95M
----
----
--849
--0
--849
----
----
--0
--0
Net other financing activities
---157.5K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
57.02%2.85M
-99.72%41K
-15.87%3.84M
423.26%21.01M
-100.44%-17.7K
--1.81M
--14.65M
--4.56M
-90.63%4.01M
-85.42%4.01M
Net cash flow
Beginning cash position
-66.76%3.79M
77.67%3.02M
-25.50%2.27M
-88.95%3.05M
34.38%7.02M
-16.47%11.39M
-91.24%1.7M
-88.95%3.05M
275.82%27.62M
-13.47%5.22M
Current changes in cash
94.69%-231.85K
-92.11%764.79K
155.25%747.13K
96.83%-778.62K
-118.57%-4.75M
48.05%-4.37M
267.81%9.69M
83.53%-1.35M
-221.20%-24.57M
-110.06%-2.17M
End cash Position
-49.38%3.55M
-66.76%3.79M
77.67%3.02M
-25.50%2.27M
-25.50%2.27M
34.38%7.02M
-16.47%11.39M
-91.24%1.7M
-88.95%3.05M
-88.95%3.05M
Free cash flow
50.17%-3.08M
114.60%723.79K
47.73%-3.09M
23.79%-21.79M
23.55%-4.73M
26.48%-6.18M
14.16%-4.96M
27.97%-5.92M
-26.72%-28.58M
-4.12%-6.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.27%-3.07M115.41%723.79K47.73%-3.09M23.16%-21.34M27.03%-4.56M21.12%-6.17M16.28%-4.7M26.90%-5.92M-23.15%-27.77M-5.22%-6.25M
Net income from continuing operations 11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M
Depreciation and amortization 10.87%21.04K8.60%20.5K8.35%19.97K-18.77%75.75K8.58%19.47K-19.91%18.98K-27.93%18.87K-27.56%18.43K-2.00%93.26K-27.67%17.93K
Other non cash items --360.16K--0-88.00%12K-70.97%282K---------92.75%12K-16.67%100K155,835.31%971.48K----
Change In working capital 99.28%-17.65K-68.60%277.48K-243.90%-2.01M-43,305.16%-3.12M-196.70%-951.85K-270.29%-2.46M-57.05%883.67K75.39%-583.08K-99.34%7.21K46.59%984.37K
-Change in receivables 53.12%-141.65K-120.67%-183.85K195.69%592.46K90.34%-69.27K94.79%-37.41K---302.16K--889.41K---619.12K---717.31K---717.31K
-Change in prepaid assets 100.77%5.01K-0.85%349.44K225.52%269.12K92.59%-33.65K-38.36%185.29K1.53%-654.04K432.15%352.43K435.20%82.67K49.62%-454.27K217.76%300.6K
-Change in payables and accrued expense 110.88%141.39K138.25%122.61K-35,299.17%-2.75M-248.80%-2.4M-153.15%-786.91K-1,680.12%-1.3M-114.05%-320.55K100.35%7.82K-18.17%1.61M3.39%1.48M
-Change in other current assets 97.66%-3.64K--7.02K---77.66K---414.21K---258.84K---155.37K--0--0--0--0
-Change in other current liabilities -15.56%-18.75K-1,403.98%-17.75K-0.14%-17.23K38.66%-51.33K-0.16%-16.72K24.39%-16.23K94.93%-1.18K22.63%-17.2K-1.98%-83.69K22.61%-16.69K
-Change in other working capital --0--050.00%-18.63K57.76%-147.81K40.63%-37.26K40.63%-36.85K61.77%-36.45K71.30%-37.26K-2,237.19%-349.94K87.02%-62.75K
Cash from discontinued investing activities
Operating cash flow 50.27%-3.07M115.41%723.79K47.73%-3.09M23.16%-21.34M27.03%-4.56M21.12%-6.17M16.28%-4.7M26.90%-5.92M-23.15%-27.77M-5.22%-6.25M
Investing cash flow
Cash flow from continuing investing activities 0.00%-12K45.29%-443.25K-375.75%-170K97.95%-12K-22,263.43%-810.23K1,801.63%61.65K
Net intangibles purchase and sale 0.00%-12K--------45.29%-443.25K-375.75%-170K97.95%-12K-----------810.23K--61.65K
Cash from discontinued investing activities
Investing cash flow 0.00%-12K--------45.29%-443.25K-375.75%-170K97.95%-12K---------22,263.43%-810.23K1,801.63%61.65K
Financing cash flow
Cash flow from continuing financing activities 57.02%2.85M-99.72%41K-15.87%3.84M423.26%21.01M-100.44%-17.7K1.81M14.65M4.56M-90.63%4.01M-85.42%4.01M
Net issuance payments of debt ---------------748--0--------------0--0
Net common stock issuance -96.68%60.29K--0-15.87%3.84M1,040.46%21.01M-100.96%-17.7K--1.81M--14.65M--4.56M-95.70%1.84M-93.31%1.84M
Net preferred stock issuance --------------0------------------2.17M----
Proceeds from stock option exercised by employees 347,010.48%2.95M----------849--0--849----------0--0
Net other financing activities ---157.5K------------------------------------
Cash from discontinued financing activities
Financing cash flow 57.02%2.85M-99.72%41K-15.87%3.84M423.26%21.01M-100.44%-17.7K--1.81M--14.65M--4.56M-90.63%4.01M-85.42%4.01M
Net cash flow
Beginning cash position -66.76%3.79M77.67%3.02M-25.50%2.27M-88.95%3.05M34.38%7.02M-16.47%11.39M-91.24%1.7M-88.95%3.05M275.82%27.62M-13.47%5.22M
Current changes in cash 94.69%-231.85K-92.11%764.79K155.25%747.13K96.83%-778.62K-118.57%-4.75M48.05%-4.37M267.81%9.69M83.53%-1.35M-221.20%-24.57M-110.06%-2.17M
End cash Position -49.38%3.55M-66.76%3.79M77.67%3.02M-25.50%2.27M-25.50%2.27M34.38%7.02M-16.47%11.39M-91.24%1.7M-88.95%3.05M-88.95%3.05M
Free cash flow 50.17%-3.08M114.60%723.79K47.73%-3.09M23.79%-21.79M23.55%-4.73M26.48%-6.18M14.16%-4.96M27.97%-5.92M-26.72%-28.58M-4.12%-6.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List